Genertec Universal Medical Group Co Stock

Genertec Universal Medical Group Co EBIT

The EBIT of Genertec Universal Medical Group Co (2666.HK) as of Aug 26, 2026 is 3.55 B CNY. In the previous year, EBIT was 3.60 B CNY — a change of -1.30% (lower).

EBIT

3.55 BCNY

YoY

-1.30%

Last updated:

In 2026, Genertec Universal Medical Group Co's EBIT was 3.55 B CNY, a -1.30% increase from the 3.60 B CNY EBIT recorded in the previous year.

The Genertec Universal Medical Group Co EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT
Date
EBIT
Jan 1, 2021
9.73 B CNY
Jan 1, 2022
12.04 B CNY
Jan 1, 2023
3.77 B CNY
Jan 1, 2024
3.60 B CNY
Jan 1, 2025
3.55 B CNY
Jan 1, 2026 (e)
3.67 B CNY
Jan 1, 2027 (e)
3.76 B CNY
Jan 1, 2028 (e)
3.90 B CNY
The Genertec Universal Medical Group Co EBIT history
YEAREBITYoY
est3.90 BCNY+3.60%
est3.76 BCNY+2.40%
est3.67 BCNY+3.35%
3.55 BCNY-1.30%
3.60 BCNY-4.49%
3.77 BCNY-68.70%
12.04 BCNY+23.83%
9.73 BCNY+15.31%
8.43 BCNY+219.41%
2.64 BCNY+15.65%
2.28 BCNY+18.27%
1.93 BCNY+39.32%
1.39 BCNY+39.81%
991.17 MCNY+37.03%
723.33 MCNY+65.79%
436.31 MCNY+55.22%
281.10 MCNY
Access this data via the Eulerpool API

Genertec Universal Medical Group Co Revenue

Genertec Universal Medical Group Co Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2021
11.16 B CNY
9.73 B CNY
2.27 B CNY
Jan 1, 2022
13.49 B CNY
12.04 B CNY
2.29 B CNY
Jan 1, 2023
15.92 B CNY
3.77 B CNY
2.46 B CNY
Jan 1, 2024
15.93 B CNY
3.60 B CNY
2.45 B CNY
Jan 1, 2025
16.95 B CNY
3.55 B CNY
2.58 B CNY
Jan 1, 2026 (e)
11.38 B CNY
3.67 B CNY
2.21 B CNY
Jan 1, 2027 (e)
11.72 B CNY
3.76 B CNY
2.29 B CNY
Jan 1, 2028 (e)
16.75 B CNY
3.90 B CNY
2.49 B CNY

Genertec Universal Medical Group Co Margins

Genertec Universal Medical Group Co stock margins

The Genertec Universal Medical Group Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Genertec Universal Medical Group Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Genertec Universal Medical Group Co.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
100.00 %
87.17 %
20.36 %
Jan 1, 2022
101.42 %
89.29 %
16.94 %
Jan 1, 2023
33.49 %
23.68 %
15.46 %
Jan 1, 2024
33.61 %
22.59 %
15.40 %
Jan 1, 2025
34.81 %
20.95 %
15.19 %
Jan 1, 2026 (e)
34.81 %
32.27 %
19.38 %
Jan 1, 2027 (e)
34.81 %
32.08 %
19.50 %
Jan 1, 2028 (e)
34.81 %
23.26 %
14.90 %

Genertec Universal Medical Group Co Stock analysis

What does Genertec Universal Medical Group Co do? The company Genertec Universal Medical Group Co Ltd is a Chinese company specializing in the development, production, and sale of medical devices and products. The company was founded in 1993 and is headquartered in Beijing. Genertec Universal Medical Group Co Ltd has a broad business model, operating in various sectors focused on different medical areas. This includes medical technology, healthcare management, research and development, and medical services. In the medical technology sector, the company offers a wide range of medical devices and products. This includes ultrasound machines, EKG devices, endoscopes, ventilators, operating microscopes, X-ray machines, and many other medical devices. The devices and products of Genertec Universal Medical Group Co Ltd are known for their high quality and reliability and are in high demand by doctors and clinics worldwide. In the healthcare management sector, the company focuses on developing software and IT solutions for the medical sector. This includes specialized administrative programs for hospitals and medical practices that allow for efficient management and control of patient data. The company also places great emphasis on quality and innovation in this area. In the research and development sector, Genertec Universal Medical Group Co Ltd works closely with renowned universities and research institutions. The goal is to develop innovative medical devices and products that meet the requirements of modern medicine. The company has also achieved several important breakthroughs in this field in recent years and has established itself as an important partner in medical research. In addition to the mentioned sectors, Genertec Universal Medical Group Co Ltd also provides medical services. This includes offering specialized training and further education for doctors and medical personnel. The aim is to improve medical expertise in China and internationally and thus contribute to improving the health and well-being of patients worldwide. Overall, Genertec Universal Medical Group Co Ltd is an important player in the international medical industry. With innovative products and a clear focus on quality and reliability, the company has earned an excellent reputation in recent years and will continue to play an important role in the field of medical technology in the future. Genertec Universal Medical Group Co is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Genertec Universal Medical Group Co's EBIT

Genertec Universal Medical Group Co's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Genertec Universal Medical Group Co's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Genertec Universal Medical Group Co's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Genertec Universal Medical Group Co’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Genertec Universal Medical Group Co stock

EBIT of Genertec Universal Medical Group Co is 3.55 B CNY in 2026.

EBIT of Genertec Universal Medical Group Co changed from 3.60 B CNY to 3.55 B CNY, representing a -1.30% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Genertec Universal Medical Group Co since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Genertec Universal Medical Group Co historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Genertec Universal Medical Group Co

All Key Metrics — Genertec Universal Medical Group Co